Disparities in HPV Vaccination by Health Care F...

By HEOR Staff Writer

August 12, 2024

Introduction Human papillomavirus (HPV) is a significant public health concern in the United States. Nearly one in two people aged 15 to 59 years are infected with at least one type of HPV.
New Anti-Obesity Medications Should Be Considered Preventive Health Care
Understanding the Cost and Funding of Gene Therapies
Transformation of Health Technology Assessment in Türkiye
The Shift to Value-Based Drug Pricing in the United States
Cost Savings on Generic Drugs: Transparent Pricing Models
HTA in Essential Health Benefit Package Design
Health Technology Assessment in South Africa: Towards NHI
Unlocking the Potential of Cell and Gene Therapies: A Path to Affordable Heal...
Strategies for Fair Drug Pricing: Balancing Pharmacy Viability and Cost Conta...
Transforming Healthcare: South Africa’s NHI Law Signed
Biosimilar Competition and Patient Out-of-Pocket Costs
Medical AI Future: Sustainable Reimbursement Strategies